GB201206209D0 - Marker gene based diagnosis, staging and prognosis of prostate caner - Google Patents

Marker gene based diagnosis, staging and prognosis of prostate caner

Info

Publication number
GB201206209D0
GB201206209D0 GB201206209A GB201206209A GB201206209D0 GB 201206209 D0 GB201206209 D0 GB 201206209D0 GB 201206209 A GB201206209 A GB 201206209A GB 201206209 A GB201206209 A GB 201206209A GB 201206209 D0 GB201206209 D0 GB 201206209D0
Authority
GB
United Kingdom
Prior art keywords
staging
prognosis
marker gene
gene based
based diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201206209A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Priority to GB201206209A priority Critical patent/GB201206209D0/en
Publication of GB201206209D0 publication Critical patent/GB201206209D0/en
Priority to PCT/EP2012/068810 priority patent/WO2013041731A1/en
Priority to PCT/EP2013/056510 priority patent/WO2013149904A1/en
Ceased legal-status Critical Current

Links

GB201206209A 2011-09-23 2012-04-06 Marker gene based diagnosis, staging and prognosis of prostate caner Ceased GB201206209D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB201206209A GB201206209D0 (en) 2012-04-06 2012-04-06 Marker gene based diagnosis, staging and prognosis of prostate caner
PCT/EP2012/068810 WO2013041731A1 (en) 2011-09-23 2012-09-24 Marker gene based diagnosis, staging and prognosis of prostate cancer
PCT/EP2013/056510 WO2013149904A1 (en) 2012-04-06 2013-03-27 Marker gene based diagnosis, staging and prognosis of prostate cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201206209A GB201206209D0 (en) 2012-04-06 2012-04-06 Marker gene based diagnosis, staging and prognosis of prostate caner

Publications (1)

Publication Number Publication Date
GB201206209D0 true GB201206209D0 (en) 2012-05-23

Family

ID=46176998

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201206209A Ceased GB201206209D0 (en) 2011-09-23 2012-04-06 Marker gene based diagnosis, staging and prognosis of prostate caner

Country Status (2)

Country Link
GB (1) GB201206209D0 (en)
WO (2) WO2013041731A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015070045A1 (en) * 2013-11-08 2015-05-14 Baylor College Of Medicine A novel diagnostic/prognostic markers and therapeutic target for cancer
GB201322034D0 (en) 2013-12-12 2014-01-29 Almac Diagnostics Ltd Prostate cancer classification
US10619210B2 (en) 2014-02-07 2020-04-14 The Johns Hopkins University Predicting response to epigenetic drug therapy
WO2016037000A1 (en) * 2014-09-04 2016-03-10 Miodx Method of multivariate molecule analysis
EP3037545A1 (en) * 2014-12-23 2016-06-29 The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin A DNA-methylation test for prostate cancer
CA3010052C (en) * 2015-12-30 2023-12-05 Technische Universitat Dresden Method and means for diagnosing tumours
US11795495B1 (en) * 2019-10-02 2023-10-24 FOXO Labs Inc. Machine learned epigenetic status estimator
CN113215260A (en) * 2021-06-18 2021-08-06 杭州昱鼎生物科技有限公司 Application of GSTP1, APC and RASSF1 in preparation of prostate cancer markers and kit thereof
CN116179694A (en) * 2022-11-02 2023-05-30 武汉艾米森生命科技有限公司 Application of reagent for detecting methylation level in preparation of prostate cancer diagnosis product and prostate cancer diagnosis kit
CN116083588B (en) * 2023-03-09 2023-09-12 嘉兴允英医学检验有限公司 DNA methylation site combination as prostate cancer marker and application thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4437975A (en) 1977-07-20 1984-03-20 Mobil Oil Corporation Manufacture of lube base stock oil
WO1989001050A1 (en) 1987-07-31 1989-02-09 The Board Of Trustees Of The Leland Stanford Junior University Selective amplification of target polynucleotide sequences
CA2005589C (en) 1988-12-16 2001-02-06 Thomas Raymond Gingeras Self-sustained, sequence replication system
US6066625A (en) 1998-02-03 2000-05-23 Methylgene, Inc. Optimized antisense oligonucleotides complementary to DNA methyltransferase sequences
US6953783B1 (en) 1998-10-19 2005-10-11 Methylgene, Inc. Modulation of gene expression by combination therapy
WO2004067726A2 (en) 2003-01-29 2004-08-12 Keck Graduate Institute Isothermal reactions for the amplification of oligonucleotides
CA2558649A1 (en) * 2004-03-17 2005-09-29 The Johns Hopkins University Neoplasia diagnostic compositions and methods of use
US8268549B2 (en) * 2005-04-15 2012-09-18 University Of Maryland, Baltimore Method and assay for determining methylation of GAL3 promoter for early diagnosis of prostate cancer
WO2007039291A2 (en) * 2005-10-03 2007-04-12 Epigenomics Ag Methods, apparatus and nomograms to determine prostate cancer progression
WO2009089598A2 (en) * 2008-01-18 2009-07-23 Katholieke Universiteit Leuven Msmb-gene methylation based diagnosis, staging and prognosis of prostate cancer
WO2009143603A1 (en) * 2008-05-28 2009-12-03 Genomedx Biosciences, Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer

Also Published As

Publication number Publication date
WO2013149904A1 (en) 2013-10-10
WO2013041731A1 (en) 2013-03-28

Similar Documents

Publication Publication Date Title
HK1210230A1 (en) Methods, kits and compositions for providing a clinical assessment of prostate cancer
GB201206209D0 (en) Marker gene based diagnosis, staging and prognosis of prostate caner
HK1259001A1 (en) Methods of prognosis and diagnosis of cancer
SG10201710447QA (en) Pancreatic cancer biomarkers and uses thereof
EP2847593A4 (en) Methods for predicting and detecting cancer risk
EP2691547A4 (en) Gene expression predictors of cancer prognosis
HK1213946A1 (en) Method for the diagnosis, prognosis and treatment of prostate cancer metastasis using c-maf c-maf
EP2625292A4 (en) Biomarkers of cancer
EP2867376A4 (en) Targeted rna-seq methods and materials for the diagnosis of prostate cancer
GB2515414B (en) Data staging area
EP2888370A4 (en) Methods for diagnosis, prognosis and methods of treatment
SG11201500396TA (en) Tumor vaccination
EP2686447A4 (en) Prognostic marker sets for prostate cancer
EP2885429A4 (en) Diagnostic markers of indolent prostate cancer
SG11201402115TA (en) Methods for diagnosis and/or prognosis of gynecological cancer
PT3536334T (en) Cancer stem cell targeted cancer vaccines
EP2885428A4 (en) Gene expression profile associated with prostate cancer
GB201414102D0 (en) Colorectal cancer diagnosis and indication marker
EP2882869A4 (en) Prostate cancer gene expression profiles
EP2932273A4 (en) Methods for diagnosing and treating prostate cancer
EP2802648A4 (en) Cancer-specific suicide gene for cell-based and gene therapy
EP2709730A4 (en) Treatment and prognosis of cancer
GB201200691D0 (en) Tunnel Lining
EP2732287A4 (en) Methods of diagnosing cancer
SG11201501838RA (en) Completion assembly and methods for use thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)